Alireza Tojjari, Yassine Alami Idrissi, Yuming Shi, Meghana Singh, John Rhee, Monica Malhotra et al. Longitudinal Albumin–Bilirubin Trajectory and Survival During Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma. // Cancer Medicine. – 2026. – DOI: 10.1002/cam4.72506. – URL: https://onlinelibrary.wiley.com/doi/10.1002/cam4.72506?af=R
Alireza Tojjari, Yassine Alami Idrissi, Yuming Shi, Meghana Singh, John Rhee, Monica Malhotra, David Geller, Ammar Sarwar, Stela Celaj, Scott W. Biggins, & Anwaar Saeed (2026). Longitudinal Albumin–Bilirubin Trajectory and Survival During Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.72506
Alireza Tojjari, et al. “Longitudinal Albumin–Bilirubin Trajectory and Survival During Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma.” Cancer Medicine, 2026. doi:10.1002/cam4.72506.
@article{Tojjari2026,
title = {Longitudinal Albumin–Bilirubin Trajectory and Survival During Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma},
author = {Tojjari, Alireza and Idrissi, Yassine Alami and Shi, Yuming and Singh, Meghana and Rhee, John and Malhotra, Monica and Geller, David and Sarwar, Ammar and Celaj, Stela and Biggins, Scott W. and Saeed, Anwaar},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.72506},
url = {https://onlinelibrary.wiley.com/doi/10.1002/cam4.72506?af=R}
}